Retroscreen Buys Proteomics Firm Activiomics for $6.7M | GenomeWeb

NEW YORK (GenomeWeb News) – Retroscreen Virology Group today announced it has acquired proteomics firm Activiomics for up to £4.0 million ($6.7 million).

In connection with the deal, Retroscreen is issuing up to £4.0 million of new ordinary shares of £.05 each of its stock, it said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.